EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Developing and Monitoring a Standard-of-Care Chimeric Antigen Receptor (CAR) T Cell Clinical Quality and Regulatory Program

Sylvia O Dulan, Kathie L Viers, Jamie R Wagner, Mary C Clark, Brenda Chang, Gerardo L Gorospe, Adina Londrc, Annette S Brown, Joseph Rosenthal, Eileen P Smith, Stephen J Forman, David S Snyder und 1 weitere

Biology of Blood and Marrow Transplantation · 2020-08 · 26 (8) · 1386-1393

DOI: 10.1016/j.bbmt.2020.03.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology of Blood and Marrow Transplantation, 2020-08. Verfasst von Sylvia O Dulan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Quality, Risk, and Regulatory Management, City of Hope National Medical Center, Duarte, California. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationReceptors, Chimeric AntigenAccreditationHumansQuality of Health CareT-Lymphocytes

Stichwörter der Autor:innen

AccreditationCellular therapyChimeric antigen receptor (CAR) T cellsFoundation for the Accreditation of Cellular Therapy (FACT)Government regulationImmune effector CellQuality management

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Quality, Risk, and Regulatory Management, City of Hope National Medical Center, Duarte, California.
  • Department of Hematology T Cell Therapeutics Research Laboratory, City of Hope Medical Center, Duarte, California.
  • Department of Hematology, The Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Duarte, California.
  • Department of Nursing Support Hem/HCT Nurse Coordinator, City of Hope Medical Center, Duarte, California.
  • Department of Hematology, Division of Transplant and Cellular Therapy Reporting, City of Hope Medical Center, Duarte, California.
  • Department of Hematology T Cell Therapeutics Research Laboratory, City of Hope Medical Center, Duarte, California; Department of Hematology, The Hematologic Malignancies and Stem Cell Transplantation Institute, City of…

Zitieren

APA

Dulan, S. O., Viers, K. L., Wagner, J. R., Clark, M. C., Chang, B., Gorospe, G. L., Londrc, A., Brown, A. S., Rosenthal, J., Smith, E. P., Forman, S. J., Snyder, D. S., & Budde, L. E. (2020). Developing and Monitoring a Standard-of-Care Chimeric Antigen Receptor (CAR) T Cell Clinical Quality and Regulatory Program. Biology of Blood and Marrow Transplantation, 26(8), 1386-1393. https://doi.org/10.1016/j.bbmt.2020.03.021

Vancouver

Dulan SO, Viers KL, Wagner JR, Clark MC, Chang B, Gorospe GL, et al. Developing and Monitoring a Standard-of-Care Chimeric Antigen Receptor (CAR) T Cell Clinical Quality and Regulatory Program. Biology of Blood and Marrow Transplantation. 2020;26(8):1386-1393. doi:10.1016/j.bbmt.2020.03.021

BibTeX
@article{Dulan2020,
  author = {Dulan, Sylvia O and Viers, Kathie L and Wagner, Jamie R and Clark, Mary C and Chang, Brenda and Gorospe, Gerardo L and Londrc, Adina and Brown, Annette S and Rosenthal, Joseph and Smith, Eileen P and Forman, Stephen J and Snyder, David S and Budde, Lihua E},
  title = {Developing and Monitoring a Standard-of-Care Chimeric Antigen Receptor (CAR) T Cell Clinical Quality and Regulatory Program},
  journal = {Biology of Blood and Marrow Transplantation},
  year = {2020},
  volume = {26},
  number = {8},
  pages = {1386--1393},
  doi = {10.1016/j.bbmt.2020.03.021}
}
Kostenlos starten →